A Q&A with TargetCancer Foundation on Comprehensive Genomic Profiling and its relevance in rare cancers and cancer of unknown primary, as well as its incorporation in the TRACK Study.
Featuring:
Jim Palma, Executive Director, TargetCancer Foundation
Dr. Prasanth Reddy, VP of Medical Affairs, Foundation Medicine